HPM Partners »

Humacyte shares owned by HPM Partners

Quarter-by-quarter ownership of Humacyte (HUMA) shares owned by HPM Partners from 13F filings

Historical chart of HPM Partners investment in Humacyte

Tip: Access up to 7 years of quarterly data

All positions including Humacyte held by HPM Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Humacyte by HPM Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $29k 48k 0.61
2025-06-30 $35k 17k 2.09

More positions owned by HPM Partners

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Microsoft Corporation (MSFT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Amazon (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Procter & Gamble Company (PG)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Msci Usa Qlt Fct (QUAL)

View all positions for HPM Partners

Top funds holding Humacyte

BlackRock
Vanguard Group
Vanguard Capital Management
Antipodes Partners
Dr. Jeffrey R. Jay, M.D.
Geode Capital Management
State Street Corporation
UBS Group
Woodline Partners
AQR Capital Management
Susquehanna International
Vanguard Portfolio Management
Charles Schwab Investment Management
Northern Trust
Vanguard Fiduciary Trust

View all funds holding Humacyte